Dr. Xiangxiang Zheng, Jiangsu Province Hospital, China
Dr. Xiangxiang Zheng, a dedicated cardiac surgeon at Jiangsu Provincial People’s Hospital since 2008, specializes in minimally invasive treatments for heart valve diseases and stem cell therapy for myocardial infarction. With a PhD and over 300 cardiac surgeries performed annually, he is at the forefront of cardiovascular innovation. His notable publications include research on engineering extracellular vesicles for diagnosis and therapy, and comparing surgical techniques for atrial septal defect repair. Dr. Zheng’s work significantly contributes to advancing surgical practices and improving patient outcomes. He is 42 years old and married. ā¤ļøšØāāļøš
Publication profile
Scopus
Professional Experience
Since 2008, Dr. Xiangxiang Zheng has been an esteemed cardiac surgeon in the Department of Cardiovascular Surgery at Jiangsu Provincial People’s Hospital. With over 300 cardiac surgeries performed annually, he has established himself as a leader in the field. Dr. Zheng specializes in minimally invasive treatments for heart valve diseases, which significantly reduce recovery time and improve patient outcomes. His expertise also extends to stem cell therapy for myocardial infarction, where he employs innovative techniques to enhance heart repair and regeneration. Dr. Zheng’s dedication to advancing cardiovascular care is evident through his hands-on surgical practice and commitment to exploring new methodologies in cardiac surgery. He continuously strives to improve surgical techniques and patient safety, making a lasting impact on the lives of those he treats. His contributions not only elevate the standard of care in his department but also serve as an inspiration to his colleagues and the medical community. ššØāāļøš
Research Focus
Dr. Xiangxiang Zhengās research primarily focuses on cardiovascular surgery, particularly in innovative surgical techniques and therapies for heart diseases. His work emphasizes minimally invasive procedures, such as thoracoscopic surgeries for atrial septal defect repair, as well as advanced myocardial protection strategies during complex cardiac surgeries. Additionally, Dr. Zheng explores stem cell therapy and the engineering of extracellular vesicles for therapeutic applications, enhancing diagnosis and treatment methods in cardiology. His research also delves into the physiological impacts of surgical interventions on heart function and the progression of pulmonary arterial hypertension, contributing significantly to the field of cardiovascular medicine. š„šāØ
Publication Top Notes
- Engineering extracellular vesicles for diagnosis and therapy š§¬
Fei, Z., Zheng, J., Zheng, X., Ren, H., Liu, G.
Trends in Pharmacological Sciences, 2024.
Cited by: 0
- The Impact of Highly Selective Thoracic Sympathectomy on the Progression of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats š
Liu, W., Men, C., Liu, Z., Zhang, L., Zheng, X.
Journal of Physiological Investigation, 2024, 67(4), pp. 207-214.
Cited by: 0
- Triport Periareolar Thoracoscopic Surgery versus Right Minithoracotomy for Repairing Atrial Septal Defect in Adults š
Zheng, X.-X., Wang, Z.-Y., Ma, L.-Y., Qin, J.-W., Shao, Y.-F.
Interactive Cardiovascular and Thoracic Surgery, 2021, 32(2), pp. 313-318.
Cited by: 5
- Comparison of Myocardial Protection Effect between Del Nido Cardioplegia and Cold Blood Cardioplegia in Complex Cardiac Surgery š
Jiao, S.-Y., Liu, L., Ma, L.-Y., Zheng, X.-X., Qin, J.-W.
Chinese Journal of Clinical Research, 2020, 33(6), pp. 807-810.
Cited by: 0
- Myocardial Protective Effect of Three Cardioplegia in Adult Valve Replacement š
Liu, H., Jiao, S.-Y., Ma, L.-Y., Zheng, X.-X., Qin, J.-W.
Chinese Journal of Clinical Research, 2019, 32(6), pp. 775-778.
Cited by: 1
- Bilateral Superior Cervical Ganglionectomy Attenuates the Progression of Ī²-Aminopropionitrile-induced Aortic Dissection in Rats š§Ŗ
Liu, H., Zheng, X., Zhang, L., Shao, Y., Zhang, S.
Life Sciences, 2018, 193, pp. 200-206.
Cited by: 5
- Cardiac Autotransplantation for Repair of Left Ventricular Rupture after Mitral Valve Replacement š„
Ni, B., Zheng, X., Zhang, S., Shao, Y.
Interactive Cardiovascular and Thoracic Surgery, 2017, 25(1), pp. 150-152.
Cited by: 3
- Three Circulating LncRNA Predict Early Progress of Esophageal Squamous Cell Carcinoma š¬
Hu, H.-B., Jie, H.-Y., Zheng, X.-X.
Cellular Physiology and Biochemistry, 2016, 40(1-2), pp. 117-125.
Cited by: 68
- High Expression of LncRNA PVT1 Promotes Invasion by Inducing Epithelial-to-Mesenchymal Transition in Esophageal Cancer š
Zheng, X., Hu, H., Li, S.
Oncology Letters, 2016, 12(4), pp. 2357-2362.
Cited by: 85
- Myxoid Fibrosarcoma of the Left Atrium and Ventricle in Pregnancy š¶ā¤ļø
Zhang, W., Zheng, X., Ni, B., Shao, Y., Zhang, S.
Annals of Thoracic Surgery, 2014, 98(5), pp. 1818-1819.
Cited by: 3